Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,981 to 2,000 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative vectors for regulated expression of SARS-CoV-2 proteins implicated in RNA metabolism. | Wellcome Open Res | 2020 | 33313418 | PubTator, text mining | PubMed |
| Does Virus-Receptor Interplay Influence Human Coronaviruses Infection Outcome? | Med Sci Monit | 2020 | 33311429 | PubTator, text mining | PubMed |
| Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease. | Front Chem | 2020 | 33304884 | PubTator, text mining | PubMed |
| Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2. | Cells | 2020 | 33302501 | PubTator, text mining | PubMed |
| Whole Genome Characterization and Evolutionary Analysis of G1P[8] Rotavirus A Strains during the Pre- and Post-Vaccine Periods in Mozambique (2012-2017). | Pathogens | 2020 | 33291333 | PubTator, text mining | PubMed |
| Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CLpro, Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach. | Antibiotics (Basel) | 2020 | 33287311 | PubTator, text mining | PubMed |
| Editorial: Proteins of SARS CoV-2, the Cause of COVID-19, and the Proteins that Interact with Them. | Protein J | 2020 | 33278013 | PubTator, text mining | PubMed |
| Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein. | PLoS Pathog | 2020 | 33264373 | PubTator, text mining | PubMed |
| Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations. | J Phys Chem B | 2020 | 33264025 | PubTator, text mining | PubMed |
| Outbreak associated with Rotavirus G11,P[25] in Korea in 2018. | Infect Chemother | 2020 | 33263243 | PubTator, text mining | PubMed |
| Current and Future Direct-Acting Antivirals Against COVID-19. | Front Microbiol | 2020 | 33262747 | PubTator, text mining | PubMed |
| SARS coronavirus 2: from genome to infectome. | Respir Res | 2020 | 33261606 | PubTator, text mining | PubMed |
| Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. | Mol Cell | 2020 | 33259812 | PubTator, text mining | PubMed |
| A pocket guide on how to structure SARS-CoV-2 drugs and therapies. | Biochem Soc Trans | 2020 | 33258925 | PubTator, text mining | PubMed |
| Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic. | Appl Biol Chem | 2020 | 33251389 | PubTator, text mining | PubMed |
| Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease. | Virol J | 2020 | 33243253 | PubTator, text mining | PubMed |
| Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. | Proc Natl Acad Sci U S A | 2020 | 33239446 | PubTator, text mining | PubMed |
| Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses. | Genet Mol Biol | 2020 | 33237152 | PubTator, text mining | PubMed |
| Minireview of progress in the structural study of SARS-CoV-2 proteins. | Curr Res Microb Sci | 2020 | 33236001 | PubTator, text mining | PubMed |
| Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2. | Bull Natl Res Cent | 2020 | 33230386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=100